Status:
UNKNOWN
Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Lead Sponsor:
Pharmaceuticals and Medical Devices Agency, Japan
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
Brief Summary
The purpose of this study is to integrate the post-marketing surveillances data (Specified use-results surveys on long-term treatment) of the 6 SGLT2 inhibitors approved or applied in Japan and to eva...
Eligibility Criteria
Inclusion
- Patients with Type 2 diabetes mellitus starting medication of SGLT2 inhibitors
Exclusion
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
18000 Patients enrolled
Trial Details
Trial ID
NCT02284269
Start Date
October 1 2014
Last Update
April 4 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.